Literature DB >> 23732152

Assessment of drug compliance in patients with high blood pressure resistant to antihypertensive therapy.

Bernard Waeber1, François Feihl.   

Abstract

The persistence of high blood pressure under antihypertensive treatment (resistant hypertension) entails an increased cardiovascular risk. It occurs in three of ten treated hypertensive patients, and has several possible contributing factors, notably insufficient therapeutic adherence. There are a number of ways to evaluate whether patients take their medication as prescribed. These include interviewing the patient, pill counting, prescription follow-up, assay of drugs in blood or urine, and use of electronic pill dispensers. None is perfect. However, the essential is to discuss with the patient the importance of complying with the treatment as soon as it is prescribed for the first time, and not waiting for the appearance of resistant hypertension. The measurement of blood pressure outside the medical office and the monitoring of adherence may help to identify patients in whom hypertension is truly resistant and so to tailor the measures required to improve the control of blood pressure in the most appropriate manner.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23732152     DOI: 10.4244/EIJV9SRA6

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  4 in total

1.  Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis.

Authors:  Sebastian Ewen; Markus R Meyer; Bodo Cremers; Ulrich Laufs; Andreas G Helfer; Dominik Linz; Ingrid Kindermann; Christian Ukena; Michel Burnier; Stefan Wagenpfeil; Hans H Maurer; Michael Böhm; Felix Mahfoud
Journal:  Clin Res Cardiol       Date:  2015-08-26       Impact factor: 5.460

2.  Diagnosis and treatment of resistant hypertension: the critical role of ambulatory blood pressure monitoring.

Authors:  J Rick Turner; Eoin O'Brien
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-09-19       Impact factor: 3.738

Review 3.  Nonadherence to antihypertensive drugs: A systematic review and meta-analysis.

Authors:  Tadesse Melaku Abegaz; Abdulla Shehab; Eyob Alemayehu Gebreyohannes; Akshaya Srikanth Bhagavathula; Asim Ahmed Elnour
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

4.  Feasibility of a checklist in treating hypertension in primary care - base line results from a cluster-randomised controlled trial (check and support).

Authors:  Aapo Tahkola; Päivi Korhonen; Hannu Kautiainen; Teemu Niiranen; Pekka Mäntyselkä
Journal:  BMC Cardiovasc Disord       Date:  2018-12-19       Impact factor: 2.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.